← Evidence map

ArticleCureus2025

Deucravacitinib Treatment for Psoriasis Complicated by Myelodysplastic Syndrome Without Exacerbation of the Underlying Hematologic Disorder: A Case Report.

Yoshihito Mima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Deucravacitinib Treatment for Psoriasis Complicated by Myelodysplastic Syndrome Without Exacerbation of the Underlying Hematologic Disorder: A Case Report. | Socratic